Liu et al. [40], during an in vivo study using a DSS-induced C57BL/6 mice model of colitis, demonstrated the effects of licochalcone A, a major compound of Glycyrrhiza species, against Nrf2 deactivation during IBD. Here, NFE2L2 is linked to inflammatory bowel disease.